Axovant Sciences to Present at Upcoming Investor Conferences
02 November 2016 - 7:30AM
PR Newswire (US)
HAMILTON, Bermuda, Nov. 1, 2016 /PRNewswire/ -- Axovant
Sciences Ltd. (NYSE: AXON), a leading clinical-stage
biopharmaceutical company focused on the treatment of dementia,
today announced upcoming presentations at three investor
conferences:
- November 8 at 3:30 p.m. MST at the 25th Annual Credit Suisse
Healthcare Conference
- November 16 at 1:20 p.m. GMT at the Jefferies 2016 London
Healthcare Conference
- November 29 at 12:30 p.m. EST at the 28th Annual Piper Jaffray
Healthcare Conference
A simultaneous webcast will be available in the Investors
section of Axovant's website at www.axovant.com. A replay will be
available for 30 days following each conference.
About Axovant
Axovant Sciences Ltd. is a leading
clinical-stage biopharmaceutical company focused on acquiring,
developing and commercializing novel therapeutics for the treatment
of dementia. Axovant intends to develop a pipeline of product
candidates to comprehensively address the cognitive, functional and
behavioral aspects of dementia and related neurological disorders.
Our vision is to become the leading company focused on the
treatment of dementia by addressing all forms and aspects of this
condition.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conferences-300355228.html
SOURCE Axovant Sciences Ltd.
Copyright 2016 PR Newswire
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From Apr 2024 to May 2024
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From May 2023 to May 2024